# FDA Inspection 1277363 - GlaxoSmithKline dba Human Genome Sciences Inc - July 31, 2025

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-dba-human-genome-sciences-inc/eada8799-31c2-4b74-ac57-97ea87f50ca2
Source feed: FDA_Inspections

> FDA Inspection 1277363 for GlaxoSmithKline dba Human Genome Sciences Inc on July 31, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1277363
- Company Name: GlaxoSmithKline dba Human Genome Sciences Inc
- Inspection Date: 2025-07-31
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1277363 - 2025-07-31](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-dba-human-genome-sciences-inc/301cdf1e-2f97-4a13-9346-d197d273c543)
- [FDA Inspection 1068898 - 2018-08-30](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-dba-human-genome-sciences-inc/703b7ee9-4dc4-4bca-9987-6c8c933aac6e)
- [FDA Inspection 989778 - 2016-04-11](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-dba-human-genome-sciences-inc/729ddd1e-ba18-4f7b-b9bc-841a45bcd21b)
- [FDA Inspection 854065 - 2013-11-05](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-dba-human-genome-sciences-inc/fcad030a-10f3-4e6a-9baa-048402dcf430)
- [FDA Inspection 805643 - 2012-11-02](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-dba-human-genome-sciences-inc/0e9b9b96-3de2-4874-a745-ef767350966b)

Company: https://www.keypedia.com/companies/glaxosmithkline-dba-human-genome-sciences-inc/c3dd2e54-125d-4d56-b0dc-18cb333074cc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c